| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |